Innobiochips, new sponsor of BioFIT and MedFIT 2024

News / Valentine Delabie

Improved diagnostic solutions contribute to the development of more precise and personalised medicine and improve the quality of life for patients worldwide. Founded in 2008, Innobiochips provides novel, breakthrough technologies and solutions to improve the accuracy, quality and sustainability of in vitro diagnostic approaches.

Vianney Souplet, CEO of Innobiochips:

“As part of the Eurasanté healthcare cluster since our foundation, we have a keen interest in contributing to events that promote connections and innovation in healthcare.”

Under the motto “Understanding Life“, the company focuses on diagnostic technologies for better Transplantations and Transfusions, as well as Infectious Diseases and Inflammation diagnostics. These areas of focus are reflected in the company’s three core values: Innovation, Performance and Responsibility.

With years of ISO 13485 certification, various CE-marked solutions developed, and more than 1 million biological tests produced per year, the company continues to demonstrate excellence in the field.

We are very grateful to see them support BioFIT and MedFIT!

Innobiochips, new sponsor of BioFIT and MedFIT 2024 Read More »

Join us for an exclusive pre-BioFIT tour

News / Valentine Delabie

Discover the rich healthtech ecosystem of the Hauts-de-France region

As a BioFIT 2024 participant, we are happy to invite you to join us for a day of discovery of the regional ecosystem, the day before BioFIT.

Discover the richness of our local ecosystem, its key players, networks, initiatives and innovative companies and entrepreneurs.

At the end of the day, a cocktail will be offered at the Eurasanté Hub, brand new building bringing together start-ups, companies, laboratories and plant-school specialising in health innovation.

Eurasanté and Clubster NHL (the competitiveness cluster in health, nutrition and longevity in the Hauts-de-France region) are working to create the ideal programme for this day, which promises to be full of discoveries and networking.

Detailed programme coming soon!

Join us for an exclusive pre-BioFIT tour Read More »

🐾 Discover key Animal Health opportunities at BioFIT 2024

News / Valentine Delabie

Source animal health innovations and make connections at BioFIT 2024

Join us and shape the future of animal health at BioFIT

BioFIT being devoted to fostering early stage innovation deals in Life Sciences, a few years ago the SIMV became a partner of the event and started to organise its R&D Dating for Animal Health and Innovation within BioFIT. Thanks to this collaboration, both human and animal health key players are taking part in the event.
Take a look at the dedicated animal health activities below, including conferences, innovation presentations, and one-on-one meetings.

Discover the Animal Health Highlights track of our conference programme. This dedicated track will provide critical insights into investment trends and the innovative convergence of human and animal health to address the needs of an aging population.

Tuesday, December 3^rd | 2.00 – 2.45 pm
Investors and Animal Health: Expectations and perspectives for 2025

Co-organised by:

Supported by:

Animal health market is influenced by the demand of sustainable products, the ongoing search for more efficiency, safety and quality, as well as the demographically-influenced consumer behaviour towards animal health services. Investors will discuss current animal health investments, their roadmap and how projects can reach their interest.

What is the state of market dynamics regarding animal health investments and how does it impact investors’ perspectives? How can the sector become more appealing to investors? What drives the interest for investment and what are the key points of an attractive project? What criteria do investors prioritise and how can companies reach them? What are the trends implying for 2025 and beyond?

Tuesday, December 3^rd | 3.00 – 3.30 pm
The Ageing of Man and Animal: crafting longer, happier and healthier lives for an ageing population of Pets and People through collaborative translational approaches

Not registered yet?

🐾 Discover key Animal Health opportunities at BioFIT 2024 Read More »

We are proud and thankful to benefit from GENFIT’s continued support!

News / Valentine Delabie

For its 13^th edition, BioFIT is proud to be sponsored by GENFIT, a long-time partner of the event. GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases characterised by high unmet medical needs.

Pascal Prigent, CEO of GENFIT commented:

“As a biotechnology company headquartered in the Health Cluster Eurasanté for years, we believe that creating strong connections with our health-innovation ecosystem is essential and mutually beneficial.”

In 2024, GENFIT achieved a historic milestone with the marketing authorization of elafibranor in the US, a “first-in-class” product developed in-house, all the way from discovery to the conclusion of a pivotal Phase III study. The product is now marketed and commercialized in the US by Ipsen under the trademark IQIRVO®.

Today, GENFIT focuses on ACLF, or Acute On-Chronic Liver Failure, a life-threatening condition for which there is currently no therapeutic solution. ACLF presents as a syndrome defined by a cascade of hepatic and extrahepatic organ dysfunctions and failures. In patients with liver cirrhosis and acute hepatic decompensation, ACLF can be triggered by a precipitating event that leads to a progressive functional deterioration of multiple organs with high short-term mortality.

Five different programs are now being conducted with the hope to meet the medical demand for patients in needs.

With such an advancement in their field and an example to follow in terms of innovation in the biotech sector, BioFIT is honoured to be sponsored by GENFIT and will be keen to follow their progress.

We are proud and thankful to benefit from GENFIT’s continued support! Read More »

🤝 Connect and build partnerships with innovators at BioFIT

News / Valentine Delabie

Engage with over 1,000 attendees at BioFIT 2024

Join us to be part of the future of Life Sciences!

Connect with key industry leaders at BioFIT and find your next partner among TTOs, research institutes, academia, big pharma, emerging and small biotechs, diagnostic companies, and pre-seed / seed / series A investors.

They’ll be part of the 2024 cohort of life sciences players:

ABBVIE ADBIO PARTNERS AFSSI ALIATH BIOVENTURES
BOEHRINGER INGELHEIM CAMBON PARTNERS
CAPTECH SANTE CLUSTER SCIENZE DELLA VITA
EFS EUROFINS ADME BIOANALYSES
FOURNIER MAJOIE FOUNDATION FRANCE BIOTECH
GENFIT JAPAN BIOINDUSTRY ASSOCIATION
IPSEN MARUHO DEUTSCHLAND
MEDTECH TWENTE MSD PFIZER ROCHE
SARTORIUS STEDIM BIOTECH SERVIER SIMV
SOFINNOVA PARTNERS SUPERNOVA INVEST SYNGULON
VÉTOQUINOL VIRBAC X’PROCHEM ZOETIS

More reasons to sign up today?

🤝 Maximise networking opportunities: Engage in meaningful conversations during the 3,000+ scheduled meetings. Whether you’re looking for collaborators or investors, BioFIT is the place to be!

🚀 Showcase your innovations: Stand out from 50+ innovators. Pitch your project and attract the attention of key decision makers looking for breakthrough innovations.

💡 Gain insights from thought leaders: Attend our conference programme featuring 60+ international experts sharing their views on the latest trends, challenges and opportunities in the life sciences sector.

🔬 Explore cutting-edge research: Meet with academic researchers and technology transfer officers ready to discuss their latest findings and explore potential partnerships.

📈 Stay ahead of the curve: Discover the latest advances in biotech, pharma and animal health. Learn how to navigate the evolving landscape and stay competitive in the industry.

🤝 Connect and build partnerships with innovators at BioFIT Read More »

Interview of Marco Catucci winner of the pitch sessions 2023

News / Julie Palomba

Marco Catucci winner of the Collaborative and Licensing Opportunity Presentations 2023

Marco Catucci interview on BioFIT 2023

What brought you to BioFIT? What are the objectives of your project? What does the award mean for your innovation?

Find out more about Ospedale San Raffaele and its involvement in Biofit 2023

San Raffaele is a Scientific Institute of Hospitalisation and Care and a University Hospital of international importance and high specialisation. It is a place that combines high-tech, state-of-the-art care and a multidisciplinary approach.

The San Raffaele University and Research Hospital, represented by Marco Catucci, won the Start-Up Slams award for the most promising technology for their CAR/TCR T Cell therapy project. This award was a unique opportunity for the project:

“It was an honour to present the CAR-T cell therapy developed by our institute here in this really important event. I think that this event and the pitch give me the possibility to promote this project and to make it visible to very important pharmaceutical companies that I hope will be interested in licensing this technology”.

About the pitch sessions BioFIT 2024

Start-up Slams

The Start-up Slams are a great opportunity for young companies (and particularly start-ups seeking to raise a seed or a Series A financing round) to showcase their project in front of potential partners and investors in the Life Sciences field.

Collaborative and Licensing Opportunity Presentations

The Collaborative and Licensing Opportunity Presentations are a great opportunity for TTOs, universities, research institutes and companies to showcase their early-stage technologies in front of potential partners in the Life Sciences field, in order to entail a collaborative project and/or a licensing deal.

Animal Health Presentations

The Animal Health Presentations are a great opportunity for young companies, TTOs, universities, research institutes and companies to showcase their innovative project in front of potential partners and investors in the Animal Health sector.

Interview of Marco Catucci winner of the pitch sessions 2023 Read More »

Stay informed about the latest advancements in science, laboratory, and research

News / Valentine Delabie

La Gazette du LABORATOIRE is a meeting and exchange point, accessible to all players in the world of Laboratories and Sciences. Created by a scientist for scientists, La Gazette du LABORATOIRE has been supporting the life of French-speaking laboratories in Research, Development, Analysis, and Control since 1995.

Discover our French edition, our Africa edition, and our websites www.gazettelabo.fr and www.LABORATOIRE.com:

Articles and specific content
Resources for your daily work
Practical and technical advice
Professional testimonials, training, job announcements
Information on events related to the field of laboratories and sciences
Tools to communicate about your news, projects, and to increase your notoriety
A search engine dedicated to services and equipment in the field of laboratories and sciences

La Gazette du LABORATOIRE, a human-sized team, at your service – for any questions: contact us! or call us at +33(0)4 77 72 09 65.

Want to join them as a media partner of MedFIT?

Stay informed about the latest advancements in science, laboratory, and research Read More »

Discover who will be attending BioFIT 2024

News / Valentine Delabie

Meet the key life sciences players at BioFIT

BioFIT is fast approaching and we are delighted to announce the leading Life Sciences companies that will be attending the event.
Take advantage of the event to meet key players such as:

AGENT BIOTECH
ASEPTIC TECHNOLOGIES
ATLANPOLE
BIOCYTOGEN PHARMACEUTICALS
BRENUS PHARMA
CARBOGEN AMCIS
CARNOT FRANCE FUTUR ELEVAGE
CASINVENT
CEA
CER GROUPE
DEEPTOPE
DR LANG MANAGEMENT CONSULTING
EFS
FONDAZIONE TELETHON
GENFIT
HC NEXT
HTL BIOTECHNOLOGY
INVESTIR &+
IOCB TECH – XMANs
ICARE LABORATORY
LUXEMBOURG INSTITUTE OF SCIENCE & TECHNOLOGY (LIST)

MARSHALL BIORESOURCES – UTOPIA
MI:RNA
MICROSYNTH
NANOREVIV
NOVALIX
NOVAPTECH
PFIZER
PRACIPIO
PROVAXS
ROOWIN
SARTORIUS STEDIM BIOTECH
SELVITA
SERVIER
SPECIPIG
SUPERNOVA INVEST
SYNERLAB GROUP
VETOQUINOL
VIRBAC
X’PROCHEM
YES MY PATENT
ZOETIS

…and many others!

By attending BioFIT, you will have the opportunity to network with these industry leaders, learn from their experiences and explore partnership, investment and licensing opportunities.

Not registered yet?

⏰ Register before July 4^th, 2024 to
benefit from the Early Bird offer!

Discover who will be attending BioFIT 2024 Read More »

Enhance your presence at BioFIT 2024

News / Valentine Delabie

Exhibit at BioFIT 2024

Secure your spot before it's too late!

BioFIT is Europe’s leading partnering event for early-stage deals and investment rounds that bring together 1,000 key players from the Life Sciences sector.
TTOs, research institutes and academia will be present together with big pharma, emerging and small biotech, diagnostic companies, pre-seed / seed / Series A investors from the Life Sciences industry.

Exhibit at BioFIT to be recognised as one of these key innovation players in Life Sciences and to benefit from high visibility!

Why book your stand today?

💡Present your innovative solutions to an international audience of decision-makers, investors and potential collaborators.

🤝 Maximise your networking opportunities: meet leading experts, researchers and industry professionals in the sector who can provide valuable insights, partnerships and funding opportunities.

📢Promote your organisation: by exhibiting at BioFIT, you will benefit from extensive brand visibility (mention in our printed communications, highlight on the exhibition floor plan, additional visibility on our website and on the partnering platform) and recognition as a key player in the life sciences sector.

🐤 The early bird offer is still running, so take advantage of the discounted fare before July 4th

Availability is limited and our stands are allocated on a first come, first served basis.

They already booked their stand:
Eurofins Amatsi Analytics, Carnot France Futur Élevage, Groupe Synerlab,
Microsynth, New England Biolabs, Novalix, Unither,
Wuxi AppTec, X’Prochem, Zoetis, and many others…

⏰ Book your stand before July 4^th, 2024 to
benefit from the Early Bird offer!

Enhance your presence at BioFIT 2024 Read More »

BioFIT 2024: Don’t miss out on our key activities

News / Valentine Delabie

As we draw closer to BioFIT 2024, we are excited to remind you of the wide range of activities and opportunities that await you at this year’s event.

BioFIT is Europe’s leading partnering event for early-stage deals and investment rounds, bringing together 1,000 innovators, investors and industry leaders from the Life Sciences sector.
Through its one-on-one meetings, conferences, pitch competition, Project – CEO matchmaking activity and exhibition area, BioFIT aims to stimulate innovation, promote biotech and pharma solutions, and shape the future of the healthcare industry.

What does BioFIT have in store for you?

One-on-one meetings: BioFIT’s partnering platform is your chance to forge meaningful connections that could drive your projects forward.
The partnering activity enables BioFIT’s participants to meet each other during 30-minute pre-qualified one-on-one meetings organised prior to the event.

Conference and roundtable discussions: Steered by a prestigious Committee, the BioFIT conference programme brings together bright minds to discuss the latest trends in the biotech and Life Sciences fields. A range of themed tracks will help you learn about the current issues, challenges and innovations.

Pitch sessions: BioFIT pitch sessions identify the most innovative and promising start-ups, companies, R&D projects and licensing opportunities in the Life Sciences and Animal Health sectors. Gain visibility, receive valuable feedback, and unlock opportunities for funding and partnerships.

Exhibition: The exhibition area enables participants to access key information, expand their network, highlight their skills, services and innovations, boost their visibility and generate informal meetings.

Project – CEO matchmaking: As talented CEOs are frequently sought-after by many players in the Life Sciences industry, the Project – CEO matchmaking activity aims to connect representatives of emerging start-ups, technology transfer offices, incubators and investing networks with CEOs and aspiring CEOs.

Not convinced yet?
Get a taste of BioFIT by watching last year’s aftermovie:

⏰ Register before July 4^th, 2024 to
benefit from the Early Bird offer!

BioFIT 2024: Don’t miss out on our key activities Read More »